![Stefan Luzi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stefan Luzi
Directeur/Membre du Conseil chez
Amphista Therapeutics Ltd.
Profil
Stefan Luzi currently works at Amphista Therapeutics Ltd., as Non-Executive Director and Gilde Healthcare Partners BV, as Partner from 2017.
Dr. Luzi also formerly worked at LAVA Therapeutics NV, as Non-Executive Director from 2021 to 2023 and Draupnir Bio ApS, as Director.
Dr. Luzi received his graduate degree in 2009 and doctorate degree in 2013 from the University of Cambridge and undergraduate degree in 2006 and graduate degree in 2008 from Swiss Federal Institute of Technology.
Postes actifs de Stefan Luzi
| Sociétés | Poste | Début |
|---|---|---|
Gilde Healthcare Partners BV
 Gilde Healthcare Partners BV Investment ManagersFinance Gilde Healthcare Partners invests in lower middle market companies located in North America and Europe with an EBITDA of EUR 3 -20 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed, early, later, buyout and growth stage capital requirements with an investment size of EUR 50 million. It takes both minority and majority positions. | Private Equity Investor | 01/08/2017 |
Amphista Therapeutics Ltd.
 Amphista Therapeutics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Directeur/Membre du Conseil | - |
Anciens postes connus de Stefan Luzi
| Sociétés | Poste | Fin |
|---|---|---|
| LAVA THERAPEUTICS | Directeur/Membre du Conseil | 09/03/2023 |
Draupnir Bio ApS
 Draupnir Bio ApS BiotechnologyHealth Technology Operates as a biotechnology company that develops oral and small molecule degraders of extracellular diseases | Directeur/Membre du Conseil | - |
Formation de Stefan Luzi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss Federal Institute of Technology
 Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gilde Healthcare Partners BV
Gilde Healthcare Partners BV Investment ManagersFinance Gilde Healthcare Partners invests in lower middle market companies located in North America and Europe with an EBITDA of EUR 3 -20 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed, early, later, buyout and growth stage capital requirements with an investment size of EUR 50 million. It takes both minority and majority positions. | Finance |
LAVA Therapeutics NV
 LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer | Health Technology |
Amphista Therapeutics Ltd.
Amphista Therapeutics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Draupnir Bio ApS
Draupnir Bio ApS BiotechnologyHealth Technology Operates as a biotechnology company that develops oral and small molecule degraders of extracellular diseases | Health Technology |
